Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Duke Heart Laser study

This article was originally published in The Gray Sheet

Executive Summary

A study of the TMR laser by Duke University's Carolyn Donovan, MD, et al., which looked at clinical outcomes for patients with end-stage coronary artery disease, showed 75% of patients improving by one angina class at 6 months post-TMR and 50% showing sustained clinical improvement at one year. The 30-patient study indicates that maximal benefit from the procedure seems to occur at 6 months but that the mechanisms for clinical improvement following TMR remain elusive. Improvement of two angina classes occurred in 17% of the patients studied at 6 months. At 12 months, one and two angina class improvement was 50% and 13% respectively

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel